Xiaomin Zhu

机构：Guangzhou University of Chinese Medicine, Nanjing General Hospital of Nanjing Military Command, Ji Hua Laboratory, Second Hospital of Shandong University, Nanjing Medical University, Chongqing Medical University, Nanjing University · ORCID：0000-0002-4647-2180

发表论文 29 篇 · 总被引 513 次 · h-index 15

代表论文

• The Global Burden of Glaucoma: Findings from the Global Burden of Disease 2019 Study and Predictions by Bayesian Age–Period–Cohort Analysis (2023 · Journal of Clinical Medicine · 被引 94)
• miR‐203a‐3p.1 targets IL ‐24 to modulate hepatocellular carcinoma cell growth and metastasis (2017 · FEBS Open Bio · 被引 44)
• Recent Advances in Asialoglycoprotein Receptor and Glycyrrhetinic Acid Receptor-Mediated and/or pH-Responsive Hepatocellular Carcinoma- Targeted Drug Delivery (2020 · Current Medicinal Chemistry · 被引 34)
• Anticancer activity of ruthenium(II) plumbagin complexes with polypyridyl as ancillary ligands via inhibiting energy metabolism and GADD45A-mediated cell cycle arrest (2022 · European Journal of Medicinal Chemistry · 被引 29)
• Dual-response detection of Ni 2+ and Cu 2+ ions by a pyrazolopyrimidine-based fluorescent sensor and the application of this sensor in bioimaging (2019 · RSC Advances · 被引 29)
• Thalidomide and its analogues: A review of the potential for immunomodulation of fibrosis diseases and opthalmopathy (Review) (2017 · Experimental and Therapeutic Medicine · 被引 25)